Evaluation of GM101 Injection in Patients With Parkinson's Disease

Clinical trial NCT07100171 · RECRUITING

Trial details

NCT number: NCT07100171
Sponsor: Genemagic Biosciences Co., Ltd
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2025-05-29
Primary completion: 2027-02-17
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.